These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

412 related articles for article (PubMed ID: 17803749)

  • 1. Clinical relevance of cytomegalovirus infection in patients with disorders of the immune system.
    Steininger C
    Clin Microbiol Infect; 2007 Oct; 13(10):953-63. PubMed ID: 17803749
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytomegalovirus infection in solid organ transplant recipients: new challenges and their implications for preventive strategies.
    Singh N
    J Clin Virol; 2006 Apr; 35(4):474-7. PubMed ID: 16406798
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytomegalovirus infection in immunocompetent and immunocompromised individuals--a review.
    Vancíková Z; Dvorák P
    Curr Drug Targets Immune Endocr Metabol Disord; 2001 Aug; 1(2):179-87. PubMed ID: 12476798
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevention of cytomegalovirus disease in recipients of solid-organ transplants.
    Paya CV
    Clin Infect Dis; 2001 Feb; 32(4):596-603. PubMed ID: 11181123
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improving outcomes for solid-organ transplant recipients at risk from cytomegalovirus infection: late-onset disease and indirect consequences.
    Legendre C; Pascual M
    Clin Infect Dis; 2008 Mar; 46(5):732-40. PubMed ID: 18220478
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Late and atypical cytomegalovirus disease in solid-organ transplant recipients.
    Slifkin M; Tempesti P; Poutsiaka DD; Snydman DR
    Clin Infect Dis; 2001 Oct; 33(7):E62-8. PubMed ID: 11528587
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Delayed onset CMV disease in solid organ transplant recipients.
    Husain S; Pietrangeli CE; Zeevi A
    Transpl Immunol; 2009 May; 21(1):1-9. PubMed ID: 19162183
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytomegalovirus infection and disease in the new era of immunosuppression following solid organ transplantation.
    Fisher RA
    Transpl Infect Dis; 2009 Jun; 11(3):195-202. PubMed ID: 19228345
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Contemporary management of cytomegalovirus infection in transplant recipients: guidelines from an IHMF workshop, 2007.
    Griffiths P; Whitley R; Snydman DR; Singh N; Boeckh M;
    Herpes; 2008 Oct; 15(1):4-12. PubMed ID: 18983762
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis and characterization of antiviral drug-resistant cytomegalovirus isolates from solid organ transplant recipients.
    Lurain NS; Bhorade SM; Pursell KJ; Avery RK; Yeldandi VV; Isada CM; Robert ES; Kohn DJ; Arens MQ; Garrity ER; Taege AJ; Mullen MG; Todd KM; Bremer JW; Yen-Lieberman B
    J Infect Dis; 2002 Sep; 186(6):760-8. PubMed ID: 12198609
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Late-onset cytomegalovirus disease in patients with solid organ transplant.
    Meylan PR; Manuel O
    Curr Opin Infect Dis; 2007 Aug; 20(4):412-8. PubMed ID: 17609602
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytomegalovirus infection in organ transplant recipients.
    Hibberd PL; Snydman DR
    Infect Dis Clin North Am; 1995 Dec; 9(4):863-77. PubMed ID: 8747770
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Deficiency of cytomegalovirus (CMV)-specific CD8+ T cells in patients presenting with late-onset CMV disease several years after transplantation.
    Cummins NW; Deziel PJ; Abraham RS; Razonable RR
    Transpl Infect Dis; 2009 Feb; 11(1):20-7. PubMed ID: 18811629
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The case for cytomegalovirus prophylaxis in solid organ transplantation.
    Snydman DR
    Rev Med Virol; 2006; 16(5):289-95. PubMed ID: 16888821
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Strategies for managing cytomegalovirus in transplant recipients.
    Razonable RR
    Expert Opin Pharmacother; 2010 Aug; 11(12):1983-97. PubMed ID: 20642369
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A single-center experience with ganciclovir-resistant cytomegalovirus in lung transplant recipients: treatment and outcome.
    Reddy AJ; Zaas AK; Hanson KE; Palmer SM
    J Heart Lung Transplant; 2007 Dec; 26(12):1286-92. PubMed ID: 18096480
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cytomegalovirus (CMV) glycoprotein B genotypes and response to antiviral therapy, in solid-organ-transplant recipients with CMV disease.
    Humar A; Kumar D; Gilbert C; Boivin G
    J Infect Dis; 2003 Aug; 188(4):581-4. PubMed ID: 12898447
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of genetic polymorphisms in cytomegalovirus glycoprotein B on outcomes in solid-organ transplant recipients with cytomegalovirus disease.
    Manuel O; Asberg A; Pang X; Rollag H; Emery VC; Preiksaitis JK; Kumar D; Pescovitz MD; Bignamini AA; Hartmann A; Jardine AG; Humar A
    Clin Infect Dis; 2009 Oct; 49(8):1160-6. PubMed ID: 19751151
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Cytomegalovirus (CMV)].
    Mazeron MC
    Rev Prat; 1999 Dec; 49(20):2222-6. PubMed ID: 10731806
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical aspects of CMV infection after stem cell transplantation.
    Hebart H; Einsele H
    Hum Immunol; 2004 May; 65(5):432-6. PubMed ID: 15172442
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.